Background
Objective
To identify psycho-emotional (PE) and socio-economic (SE) interventions provided to TB patients and to assess the effects of these interventions on treatment adherence and treatment outcomes.
Search strategy
We searched PubMed and Embase from 1 January 1990-15 March 2015 and abstracts of the Union World Conference on Lung Health from 2010-2014 for studies reporting TB treatment adherence and treatment outcomes following SSI.
Selection criteria
Studies measuring the effects of PE or SE interventions on TB treatment adherence, treatment outcomes, and/or financial burden.
Data collection and analysis
Two reviewers independently assessed titles and abstracts for inclusion of articles. One reviewer reviewed full text articles and the reference list of selected studies. A second reviewer double checked all extracted information against the articles.
Background
In 2013, 9 million people developed TB and 1.5 million died from this disease [1, 2] . TB is the most common cause of death in people with HIV [1] . The treatment duration for TB is long, at least 6 months for drug-susceptible TB and 18-24 months for multidrug-resistant tuberculosis (MDR-TB) that does not respond to the two most effective anti-TB drugs isoniazid and rifampicin. The long treatment, adverse drug reactions during treatment, stigma and financial burden of TB contribute to non-adherence to treatment and unsuccessful treatment outcomes [3] [4] [5] [6] [7] [8] . In addition, ensuring patient adherence to treatment through facility-based directly observed therapy (DOT) competes with work related priorities of patients, adding to the financial burden coming from out-of-pocket and indirect costs related to treatment [7, 9] , even though anti-TB drugs are provided free of charge in most countries [1, 10] . The quick improvement of TB symptoms early in treatment also contributes to patients' stopping treatment prematurely (i.e. loss to follow-up) as competing interests take priority [9, 11] . Poor treatment adherence and loss to follow-up increase morbidity, mortality, and the risk of drug resistance development, and can lead to prolonged transmission of TB [12] [13] [14] [15] [16] [17] .
Adherence to tuberculosis treatment improves the chance of cure and reduces acquisition of drug resistance and ongoing transmission of TB. The use of DOT through a patient-centered approach, which often requires enablers, is recommended to encourage adherence to TB treatment [18, 19] . In some settings and circumstances, incentives alone or in addition to enablers are used to motivate patients to adhere to and complete their full course of treatment [9, 16, [20] [21] [22] . Social support through various educational, emotional, and/or material (in-kind or services) interventions are being provided by numerous TB programmes to remove or alleviate barriers to treatment adherence [9, 20, [23] [24] [25] , including the financial burden associated with TB illness and its treatment. Despite the fact that different types of social support interventions (SSI) are implemented, countries still struggle to develop systems that are able to provide SSI in an efficient, effective and sustainable way [26] . WHO guidelines for the programmatic management of drug resistant TB and the new End TB Strategy recommend the use of SSI in TB patients, though WHO has not yet systematically assessed the evidence to support such a recommendation [2, 19, 27] . Hence, a systematic review of relevant literature on the effects of SSI on TB treatment adherence, treatment outcomes, and financial burden will be informative for national and global policy making.
The primary aim of this systematic review was to identify SSI provided to TB and MDR-TB patients and assess the evidence of their effects on treatment adherence, treatment outcomes and financial burden related to TB illness. The secondary aim was to describe the funding sources for and ownership of local organizations in the identified interventions.
Methods
This review followed standard methods as defined by the Cochrane Handbook for Systematic Reviews of Interventions and the Preferred Reporting Items for Systematic Reviews and MetaAnalysis (PRISMA) guidelines [28, 29] . The PRISMA checklist is enclosed in the supporting information (S1 PRISMA Checklist).
Literature search
In this review we searched for two main categories of SSI, namely PE support and SE support. PE support includes both emotional support through psychological interventions (e.g. counseling by health care workers) and companionship support through provision of help for patients to participate in a social network (e.g. peer counseling for patients and their support network) [19] . We did not consider interventions aimed only at providing improved information or education to TB patients, given the recent systematic review showing a lack of evidence related to TB treatment [17] . In addition, reminder systems were not considered social support interventions [30] . SE support entails delivering services, material goods and/or financial assistance [19, 31, 32] . Financial assistance was categorized according to Richter et al. [7] as"direct transfers of money, such as cash paid as part of a social security system or a program incentive, transport reimbursements, treatment allowances, and the like that are paid directly to affected individuals". Indirect assistance was defined as: "indirect transfers through, for example, food packages or vouchers, travel vouchers, and payment of health insurance for individuals, households or families". Some forms of indirect assistance may also be converted into cash. We included tax exemption under indirect assistance. Enterprise assistance was defined as"training programs or microcredit that aim to assist individuals or families to generate income" [7] . We searched for studies assessing the effects of socio-economic and/or psycho-emotional interventions on treatment adherence and/or treatment outcomes and/or financial burden. The study population consisted of patients initiated on anti-TB treatment, including treatment for MDR-TB.
Outcome measures
Treatment adherence, treatment outcomes and financial burden were considered as the primary outcome measures. Adherence was calculated as the percentage of prescribed doses actually taken. Treatment outcomes were defined according to WHO definitions, where cure and completed treatment are defined as successful treatment outcomes [1] . Unsuccessful treatment outcomes for active TB treatment included death, treatment failure and loss to follow-up (previously named default). Patients with transfer-out or missing treatment outcomes were excluded from the analysis. As timing of loss to follow-up per individual was not available for studies reporting on treatment outcomes but not treatment adherence, for these studies loss to follow-up was not included in calculation of treatment adherence. Financial burden was reported according to the definitions used in the individual studies. We also extracted information about how the SSI were financed and organized.
Search strategy
We systematically searched PubMed and Embase for primary articles and reviews reporting on SSI and tuberculosis treatment for human subjects, published from 01 January 1990-15 March 2015, on the grounds that relevant old information would emerge from previous reviews and references lists. We reviewed the reference lists of identified articles, editorials and reviews. Additionally, we hand searched the 2010-2014 abstract books of the Union World Conference on Lung Health to identify recent studies that were not published in the literature yet. Databases were searched using the full text search strategy as described in S1 Web annex. We contacted authors when we were not able to extract required information from the identified publication on the SSI provided and its effects.
Eligibility criteria
Eligibility of studies was based on predetermined inclusion criteria. Original studies including a description of SSI had to be in place, as well as an evaluation of the association of SSI on treatment adherence, treatment outcome and/or financial burden. This was evaluated either by means of a comparison between outcomes of an intervention group and a group receiving standard support (which could be none or a more limited package), or by means of a comparison of the occurrence of interventions in those with positive and negative outcomes (case-control studies). The search strategy was restricted to certain languages including publications in Dutch, English, French, German, Portuguese, Russian and Spanish. No age restriction was applied. We chose not to exclude studies that did not provide DOT to their patients as there is no hard evidence that DOT in a strict sense (i.e. direct observation of medication ingestion) without the DOT provider supporting the patient through education and counseling improves treatment outcome under programmatic conditions [22, 33] .
Data collection and analysis
Selection of studies and data extraction. One reviewer conducted the literature search (RH) based on the search strategy developed by all authors. Subsequently, two reviewers (SH, RH) independently examined titles and abstracts retrieved by the search. One reviewer (RH) reviewed full texts and the reference lists of selected articles, and extracted study data, which were then verified by a second reviewer (SH). For data extraction and management, a prepiloted form was developed to list study characteristics including: study design and study aim, type(s) of patients, type(s) of TB treatment, descriptions of intervention and control group, descriptions of intervention and routine support, coverage of patients that received the intervention, results of the intervention and control group and differences between these groups. Duplicate publications of included studies were taken into account if they provided additional information. When disagreements occurred, a third independent reviewer was consulted and discrepancies were resolved by consensus among the three.
Risk of bias and quality of evidence. Risk of bias was assessed separately for Randomized Controlled Trial (RCTs) and Non Randomized Studies (NRS). We used the Newcastle Ottawa Scale for NRS [34] and The Cochrane Collaboration's Tool for RCTs [35] . Furthermore, an additional assessment was made for Cluster Randomized Trials on recruitment bias, baseline imbalance and loss of clusters [36] . For NRS, we considered <10% of subjects lost as indicative of low risk of bias. The quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) tool [37] [38] [39] [40] .
Data analysis. All SSI were described, irrespective of inclusion in the meta-analysis. We analyzed the dichotomous outcomes using Risk Ratios (RR) for RCTs and cohort studies, and Odds Ratios (OR) for case-control studies, together with corresponding 95% confidence intervals. Ratios were (re)calculated from the data provided in the publications. Subsequently, the (calculated) intervention effects were combined in the meta-analysis. Studies were assessed on clinical diversity (e.g. differences in patient spectrum, type and dose of treatment) and methodological diversity (e.g. differences in methods: blinding of patients, concealment and randomization). Additionally, (statistical) heterogeneity was examined with the I 2 test along with the visual assessment of the forest plots [28, 41] . An I 2 of 0-40% was considered as low heterogeneity, 30-60% was defined as moderate heterogeneity, 50-90% substantial heterogeneity and 75-100% as high heterogeneity [42] . Furthermore, the I 2 was interpreted along with the directions and magnitudes of the different studies observed in the forest plots. A p-value for the Chi 2 test of 0.10 was considered as a cut-off point for statistically significant heterogeneity. In case of statistically significant heterogeneity, sensitivity analysis were performed based on patient type (e.g. MDR-TB or not) and risk of bias (e.g. low vs. high risk of bias) [42] . Funnel plots were created to assess for publication bias. To execute the meta-analysis, a random effects model was used, considering the diversity in participants (e.g., susceptible TB-patients and MDR-patients) and interventions (e.g. self-help groups and counseling). The DerSimonian Laird method is based on the inverse-variance approach [42] . Due to the potential heterogeneity of the interventions (PE support, SE support and combined PE and SE support) also stratified analyses were performed [43] . Stata (STATA/SE 13.1) was used to perform the meta-analysis. To visualize the risk of bias assessment, Review Manager (Review Manager (RevMan) 5.3, The Nordic Cochrane Centre, Copenhagen) was used.
Results
In total, we identified 2443 articles. After removal of 694 duplicates, two reviewers screened titles and abstracts of the 1752 citations. Twenty-five articles were eligible for inclusion in the description of included studies (Fig 1) .
Description of included studies
Fourteen NRS and eleven RCTs were included in the description of interventions from 15 different countries. Study populations ranged from 46 to 4,091 participants. Eight studies included both children and adults [44] [45] [46] [47] [48] [49] [50] [51] . Three studies explicitly included adults [52] [53] [54] . For the other studies the age range was not reported, however mean age was provided frequently [20, [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] . Most studies were conducted in middle income countries, 9 in upper middle income countries and 7 in lower middle income countries [65] . Six studies were performed in high income countries and the remaining three studies in low income countries. Eleven studies provided SE support only, seven studies provided only PE support, while the remaining seven studies provided a combination of PE and SE support [44, 52, 56, 57, 61, 66, 67] (Table 1) . Table 2 includes a comprehensive summary of studies including the frequency of the intervention provided and sustainability of the below described interventions. Psycho-emotional support. Seven studies provided counseling, exclusively [46, 53] or in combination with other PE and or SE interventions [44, 51, 52, 61, 67] . The scope of the additional interventions varied from food supplementation [44] combined with home visits [67] , direct economic support constituted after an exploratory quality study [52] , cash coupons at every monthly visit and at the end of treatment [61] , arrangement of a self-chosen treatment supporter [51] . See Table 2 for details. Furthermore, 2 studies organized self-help groups [50, 59] , one of these studies along with stigma reduction and home visits [59] . TB clubs were raised in the form of self-help groups in combination with support to reduce stigma and home visits to get insight in the social network of the patients and to plan activities to support the patient [59] . In the second study, the patients could choose the number of meetings and the topics discussed [50] . Another 6 studies arranged home visits together with other interventions [51, 57, 59, [66] [67] [68] .
Socio-economic support. Eight studies provided food supplementation consisting of fresh food supplies [58, 60] , hot meals [44] and/or food packages [44, 45, 49, 54, 60, 67, 68] . Four of them exclusively provided food supplementation [45, 49, 58, 60] . Other studies also provided food supplementation, in combination with direct economic support and/or other material support through provision of e.g. clothing and legal support [44] , assistance in providing documentation for health care access and social security [54] , or establishing a supportive social network of organizations that could provide support to the local community, such as public day care centers and employment agencies [68] . One study additionally provided PE support [67] .
Four studies provided indirect economic support including food and transport vouchers [20, 47, 56, 61] . Coupons varying from 5 to 15 US$ were given when attending each appointment or at drug collection each month. Some studies provided additional coupons varying from 40 to 60 US$ after completion of 3 months of treatment or at the end of treatment [56, 61] . Seven studies granted direct economic support, mainly financial support varying from 19 to 240 US$ per month [44, 48, 52, 57, [62] [63] [64] . Four studies provided direct economic support exclusively [48, [62] [63] [64] . Other studies only provided economic support for the first three months and 5 US $ per month for travel expenses [57] or arranged reimbursement of travel for an unknown amount of money, combined with food supplementation, other material support and psychoemotional support [44] . The remaining three studies also combined socio-economic support with psycho-emotional support. No studies on 'enterprise assistance' were found. Details on economic support provided per study are retrievable in Table 2 .
Funding sources and organization. Information on funding sources and involvement of local bodies in the organization of the interventions can be found in Table 2 . Seven SSIs were financed through governmental funding or local authorities. Another nine interventions were funded by foreign donor assistance (e.g. WHO, Unicef). Three interventions received combined funding (local and foreign donor assistance). For the remaining five interventions the funding source was unknown.
In total nine studies provided information on the organization of interventions, including six RCTs [46, [50] [51] [52] 55, 67] and three NRS [44, 59, 66] . A study from Russia organized and implemented support by regional TB services and a local international organization [23] and a study from Nicaragua raised TB clubs organized by TB patients, with the help of local non-governmental organizations [59] . Community involvement was integrated into regular patient management in Burkina Faso [44, 59, 67] . The remaining studies reported very limited information on organizational sustainability.
Incentives and enablers. All the RCTs defined their support as incentives. Incentives are rewards for adherence while enablers assist patients to overcome barriers to treatment adherence. Most studies provided support to all TB patients. In studies where only poor patients were supported [64] ; it may be that the support in fact was in the form of enablers.
Risk of bias and quality of evidence
Risk of bias was assessed for all included RCTs, including six Cluster Randomized Trials [47, [50] [51] [52] 60, 67] . Only five out of eleven RCTs described an adequate randomization approach [50] [51] [52] 58, 60] . For the majority of the studies it was not described whether investigators were blinded to the outcome, and assessment of reporting bias was not possible due to a lack of information. None of the Cluster Randomized Trials assessed baseline imbalances between clusters or took random effects into account in the analysis. Ten NRS were assessed on risk of bias, including eight cohort studies and two case-control studies. Four studies [20, 56, 63, 66] were not included in the meta-analysis and risk of bias assessment; reasons for exclusion are described in Table 3 . Only three NRS adjusted for one or more confounders in the analysis [44, 48, 53] . Five additional studies were not included because of inadequacy of follow-up and/or assessment of outcome measures [44, 48, 53, 62, 68] . More information on the risk of bias assesment of the RCTs and NRS can be found in the supportive information S1-S3 Tables. Quality of evidence was assessed for the included RCTs per outcome measure. The quality of evidence for the RCTs was downgraded with one level for risk of bias, two levels on indirectness of studies and one level for limitations in consistency of the results. Hence, the overall quality of evidence of this systematic review is considered to be very low [40, [69] [70] [71] [72] [73] [74] . The quality of evidence per outcome measure is similar to the overall quality of evidence and retrievable in the summary of findings table (Table 4) . No rating up for the overall quality of evidence was possible. Based on the funnel plot for the results of the ten RCTs included in the meta-analysis, it was not possible to determine whether publication bias was present (Fig 2) [28] Meta-analysis Eleven RCTs, eight cohort studies, and two case-control studies were included in the metaanalysis, including 17 743 patients (9655 patients participating in RCTs and 8088 patients in NRS). Most data originated from Brazil, China, Russia, Senegal and South Africa. No evidence was found concerning the effect of SSI on financial burden. Only one NRS measured the costeffectiveness ratio of the provided economic support [64] . Studies assessing the effect of SSI on treatment adherence were too heterogeneous to pool. Meta-analysis of different outcome measures are presented separately (Figs 3 and 4) .
Treatment outcomes. In total, nine RCTs had treatment success as an outcome measure (Fig 3) . The overall effect of these studies showed a significant positive effect (RR 1.17; CI 1.09-1.25), however significant heterogeneity was observed (I 2 of 72.8%, P = <0.001). Stratified analyses were performed for the different types of interventions. Three studies provided PE support [50, 52, 55] including counseling, psychotherapy and the organization of self-help groups. A significant pooled effect was found for this intervention (RR 1.37; CI 1.08-1.73). The association between SE support and treatment success was examined by four studies [47, 49, 58, 60] providing food supplementation and economic support. A significant pooled effect was found for this intervention (RR 1.08; CI 1.03-1.13). Combined support was provided by three studies [51, 52, 67] . Also, a significant pooled effect was found for these interventions on successful treatment outcomes (RR 1.17; CI 1.12-1.22). No significant heterogeneity was observed in two of three stratified analyses (SE: I 2 of 14%, P = 0.32; combined: I 2 of 0%, P = 0.42). Studies that provided PE support were substantially heterogenic and the p-value for the Chi 2 test was significant (I 2 of 78%, P = 0.01) (Fig 3) . A sensitivity analysis was performed on the effect of PE support on treatment success, comparing high vs. low risk of bias studies. Omitting one high risk of bias study removed heterogeneity (I 2 of 0%, P = 0.53) (data not shown), and did not change effect size (RR 1.20; CI 1.07-1.35) [55] . Sensitivity analysis on MDR-TB patients vs. non-MDR-TB patients did not change the effect size and statistical significance (data not shown). Table) . Study population only includes non-adherent patients, which were their own controls. Nine studies had unsuccessful treatment outcomes as an outcome measure including seven also having treatment success as an outcome measure (Fig 4) . An overall significant protective effect was found (RR 0.53; CI 0.41-0.70), however, substantial heterogeneity was observed (I 2 of 80.2% and P = <0.001). Stratified analyses were performed on the different interventions provided. Four studies investigated the effect of PE support on unsuccessful treatment outcomes, including counseling, psychotherapy and the organization of self-help groups [46, 50, 52, 55] . Two studies examined the effect of SE support, including food supplementation and economic support [47, 58] and four studies assessed the effect of combined support [51, 52, 61, 67] . A significant reduction in unsuccessful treatment outcomes was found for all three stratified analyses: PE support (RR 0.46; CI 0.22-0.96), SE support (RR 0.78; CI 0.69-0.88) and a combination of PE and SE support (RR 0.42; CI 0.23-0.75). Heterogeneity was considered to be very low for the studies that provided SE support interventions (I 2 of 0% and P = 0.37). The studies that provided PE support and combined support were substantially heterogenic (PE: I 2 of 85%, P = <0.001 and combined: I 2 of 64% (P = 0.03) (Fig 4) . A sensitivity analysis was performed in the PE stratum on the basis of higher risk of bias compared to the other studies [46, 55] . Removal of one high-risk of bias study [46] decreased the I 2 to 0% (P = 0.54) and the effect size changed but remained statistically significant (RR 0.33; CI 0.22- 0.50). Omitting both biased studies did not change heterogeneity or the effect size. Sensitivity analysis on risk of bias was not possible in the studies providing a combination of PE and SE support, due to the fact that 3 out of 4 studies were classified as biased studies. Sensitivity analyses on MDR-TB patients vs. non-MDR TB patients did not change the effect size or heterogeneity significantly (data not shown). Treatment adherence. Three RCTs assessed the effect of PE and/or SE on treatment adherence. A PE-intervention study conducted in Mexico showed a significant improvement in treatment adherence (RR 1.20; CI 1.03-1.39). A study from the USA did not show significantly higher levels of adherence in the intervention group compared to the group that received usual care (RR 1.11; CI 0.92-1.33). A third study from Timor-Leste showed no effect for patients that received SE support compared to patients that did not receive this support (RR 1.01; CI .0.85-1.21). Above-described interventions were not pooled as they were too heterogeneous.
Financial burden. None of the RCTs examined the effect of PE or SE support on financial burden for TB patients.
Non-randomized studies. Due to the fact that the studies' characteristics were heterogeneous on several levels and at higher risk of bias than the RCTs, we chose not to pool the effects for these studies (S1 and S3 Figs) [28, 75] . Seven NRSs reported an effect of social support on successful treatment outcomes. Effects of interventions on successful treatment outcomes (RR) ranged from 1.03 to 2.51 (CI 0.96-2.99). Five of seven NRSs reported significant effect sizes [48, 54, 57, 64, 68] . Two studies found no significant effects [45, 59] . Furthermore, six NRSs examined the effect of social support on unsuccessful treatment outcomes. Effect sizes varied from RR 0.32-0.96 (CI 0.18-3.49). Five out of six NRSs showed significant beneficial effects [45, 54, 62, 64, 68] . Only one study reported a non-significant effect [59] . In addition, two casecontrol studies investigated the effect of social support on unsuccessfull treatment outcomes. Both studies showed significant beneficial effects (RR 0.51 (CI 037-0.70) and RR 0.10 (CI 0.05-0.20)).
Discussion
This review found that PE and SE support did improve treatment outcomes across a variety of settings and patient populations, with a tendency towards better outcomes with PE interventions or a combined approach. However, the quality of evidence was classified as "very low" under the GRADE approach. Food supplementation and counselling were commonly included in the package of support. PE, SE and combined interventions improved treatment outcomes; only for interventions including SE support exclusively there was no significant improvement in treatment success. Overall, support interventions were associated with significantly higher treatment success (overall RR 1.08; CI 1.03-1.13) and reductions in unsuccessful treatment outcomes (overall RR 0.53; CI 0.41-0.70). Hardly any studies assessed the effect of interventions on treatment adherence. However, improved treatment adherence is an intermediate goal with the final aim to improve treatment outcomes, which was shown to improve. A recent systematic review concluded that the economic burden for patients is considered to be high, loss of income is an important indirect cost factor for TB patients, and transport and nutritional supplementation were important direct cost components [8] . A study in Peru evaluated the expenses for MDR-TB patients that received free treatment and found that having MDR-TB was associated with high costs, which was associated with adverse outcomes (population attributable fraction 18-20%) [76] . In line with our review, these two studies suggest that economic support is of great importance for improving treatment outcomes. Some of the findings of this review however differ from those from other SSI-related reviews. A recent review [77] on RCTs assessing the effect of material incentives on TB treatment adherence and completion of TB treatment identified two trials, both included in our review as well [47, 60] , and neither demonstrated a clear benefit. However, in one trial the incentive was not well received by the patients and in the other trial fidelity to the intervention was low. A review of Sinclair et al. did not find any evidence that food supplementation had a beneficial impact on treatment outcomes [78] . This may be explained by their focus on micronutrient supplementation alone as reflected in their search strategy. In a systematic review about strategies to reduce loss to follow-up in drug-resistant patients, a comprehensive package of interventions (e.g. financial support and food supplementation) was associated with reduced loss to follow-up [79] . Our review included studies focusing on all TB patients, not only those with MDR-TB [79] . As mentioned in the methods section, we did not consider interventions aimed only at providing improved information or education to TB patients, given the recent systematic review showing a lack of its evidence related to TB treatment [17] . Some of the intervention packages included in our review included an information or education component, but it was not possible to delineate the effects of this specific component in our review. We also did not include interventions focusing only on reminder systems, as these are not considered PE or SE support. However, reminder systems can be integrated into SSI programs to enhance its effects since pre-appointment reminder phone calls and letters or home visits did have a small but potentially relevant effect on treatment completion [30] .
There were some limitations to our review. Only a limited number of studies were available on the effect of PE/SE support interventions on TB treatment outcomes and very limited evidence on treatment adherence and financial burden. Within the identified studies, we were not able to stratify results by the type of organization and quality of health service delivery due to insufficient information, although it is known that organization and quality of health service delivery influence treatment adherence [9] . Some NRSs only provided support to subgroups of patients including poor patients [64] , patients that already received support before referral to the intervention studied [66] and non-adherent patients [20] . This precludes conclusions on the effects of these interventions when provided to all patients. Such patient selection may have led to overestimations in the observed effect of the PE/SE interventions. On the other hand, selecting patients most in need seems prudent and is in practice applied in resource-limited settings. Although the number of studies included in the meta-analysis was small, the optimal size criterion was sufficient both for the overall meta-analysis and stratified analyses as examined by calculation of the sample size for the overall effect and subgroup analyses [72] . We could not examine for a dose response rate across all included studies, as most studies did not include a comprehensive description of interventions. However, one study did show a positive dose-response within their study regarding provision of indirect economic support: among patients in the intervention group who received the voucher at least once, treatment success rates significantly improved [47] . Furthermore, the more frequent the vouchers were received by patients, the higher their probability of treatment success [47] . Plausible heterogeneity was observed and seven out of eleven RCTs had a high risk of bias on one or two domains. However, we did not exclude studies on the basis of heterogeneity only, as this may introduce bias [42] .
Conclusions
This review provides evidence to endorse implementation of SSI in order to improve treatment outcomes. Firstly, PE and combined PE/SE support have a beneficial impact on treatment success. Secondly, SE support and a combination of PE/SE support are associated with reductions in unsuccessful treatment outcomes. No conclusions can be drawn considering the overall effect of PE and/or SE support on treatment adherence and financial burden due to a lack of evidence. Our findings need to be interpreted with caution, as the quality of the evidence included in the meta-analysis is "very low" based on the GRADE approach. In addition, most support included multifaceted types of interventions, so no conclusions can be drawn on the effect of individual interventions. Simultaneously, this might signify that multifaceted types of interventions are needed to improve treatment outcomes. High quality evidence, from welldesigned randomized studies in larger sized populations, would provide more certainty on the effects of different PE and SE interventions. Cluster-randomized studies would provide an opportunity to compare differential packages and delineate the importance of specific components. In addition, more systematic data collection on PE and SE as already used by TB programs to monitor implementation and evaluate its effects and qualitative data collection in both studies and program settings to assess which interventions are most appreciated and most feasible to implement on a wide scale, would be useful. Reports should include information on costs and sustainability to provide information on efficiency and scalability. 
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